Zevra Therapeutics Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: ZVRA
Share price (10/1/26): $10.18
Market cap (10/1/26): $605 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 10-Q 25 pages Execution Version Asset Purchase Agreement

from 8-K 118 pages Agreement and Plan of Merger Among Zevra Therapeutics, Inc. Aspen Z Merger Sub, Inc., and Acer Therapeutics Inc. Dated as of August 30, 2023

from S-1/A 52 pages Asset Purchase Agreement Between Shire LLC and Travis C. Mickle, PH.D., and Kempharm, Inc. Dated as of March 21, 2012

from S-1 39 pages Asset Purchase Agreement Between Shire LLC and Travis C. Mickle, PH.D., and Kempharm, Inc. Dated as of March 21, 2012

from DRS 39 pages Asset Purchase Agreement Between Shire LLC and Travis C. Mickle, PH.D., and Kempharm, Inc. Dated as of March 21, 2012